2.8692
-0.0708
(-2.41%)
As of 1:02:59 PM EST. Market Open.
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 1.62M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
BASKIES ARNOLD M Director | Purchase at price 2.82 per share. | Direct | 14,100 | Jan 28, 2025 |
TITTERTON LEWIS H JR Director | Purchase at price 2.91 - 3.00 per share. | Direct | 8,820 | Jan 24, 2025 |
TITTERTON LEWIS H JR Director | Purchase at price 3.01 per share. | Direct | 6,020 | Jan 22, 2025 |
TITTERTON LEWIS H JR Director | Purchase at price 2.59 per share. | Direct | 15,540 | Jan 21, 2025 |
TITTERTON LEWIS H JR Director | Purchase at price 2.57 per share. | Direct | 25,700 | Jan 17, 2025 |
KUMAR AMIT Chief Executive Officer | Purchase at price 2.23 per share. | Direct | 95,890 | Jan 15, 2025 |
CATELANI MICHAEL J President | Purchase at price 2.15 per share. | Direct | 19,971 | Jan 15, 2025 |
TITTERTON LEWIS H JR Director | Conversion of Exercise of derivative security at price 2.58 per share. | Direct | 41,200 | Oct 22, 2024 |
TITTERTON LEWIS H JR Director | Purchase at price 3.06 - 3.23 per share. | Direct | 84,260 | Jul 31, 2024 |
TITTERTON LEWIS H JR Director | Purchase at price 2.81 - 3.03 per share. | Direct | 25,568 | Jul 26, 2024 |
BASKIES ARNOLD M Director | Purchase at price 3.09 per share. | Direct | 15,450 | Jul 26, 2024 |
TITTERTON LEWIS H JR Director | Purchase at price 2.68 per share. | Direct | 10,720 | Jun 14, 2024 |
TITTERTON LEWIS H JR Director | Purchase at price 2.70 per share. | Direct | 1,094 | Jun 13, 2024 |
TITTERTON LEWIS H JR Director | Purchase at price 2.60 - 2.66 per share. | Direct | 19,749 | Jun 11, 2024 |
TITTERTON LEWIS H JR Director | Purchase at price 2.52 per share. | Direct | 27,060 | Jun 7, 2024 |
KUMAR AMIT Chief Executive Officer | Purchase at price 2.41 per share. | Direct | 60,250 | Jun 7, 2024 |
CATELANI MICHAEL J President | Purchase at price 2.40 per share. | Direct | 15,000 | Jun 7, 2024 |
CATELANI MICHAEL J President | Stock Award(Grant) at price 2.52 per share. | Direct | 2,996 | Apr 30, 2024 |
TITTERTON LEWIS H JR Director | Purchase at price 3.28 per share. | Direct | 49,230 | Apr 9, 2024 |
KUMAR AMIT Chief Executive Officer | Purchase at price 3.22 per share. | Direct | 96,600 | Mar 15, 2024 |
BASKIES ARNOLD M Director | Purchase at price 3.63 per share. | Direct | 36,300 | Mar 15, 2024 |
CATELANI MICHAEL J President | Stock Award(Grant) at price 2.69 per share. | Direct | 3,005 | Oct 31, 2023 |
TITTERTON LEWIS H JR Director | Conversion of Exercise of derivative security at price 2.58 per share. | Direct | 41,200 | Oct 10, 2023 |
KUMAR AMIT Chief Executive Officer | Sale at price 3.57 per share. | Direct | 42,126 | Jul 31, 2023 |
KUMAR AMIT Chief Executive Officer | Conversion of Exercise of derivative security at price 2.58 per share. | Direct | 103,000 | Jul 28, 2023 |
TITTERTON LEWIS H JR Director | Conversion of Exercise of derivative security at price 2.58 per share. | Direct | 309,000 | Jul 27, 2023 |
CATELANI MICHAEL J President | Purchase at price 3.64 per share. | Direct | 20,020 | Jul 20, 2023 |
CATELANI MICHAEL J President | Stock Award(Grant) at price 3.47 per share. | Direct | 3,002 | Apr 28, 2023 |
Related Tickers
ZYME Zymeworks Inc.
14.82
+0.51%
FBIO Fortress Biotech, Inc.
1.8309
+2.86%
LCTX Lineage Cell Therapeutics, Inc.
0.6550
+4.58%
INTS Intensity Therapeutics, Inc.
2.3300
+3.56%
SABS SAB Biotherapeutics, Inc.
2.1200
-2.30%
COYA Coya Therapeutics, Inc.
6.17
+5.29%
INMB INmune Bio, Inc.
9.95
+7.92%
ADAG Adagene Inc.
1.8700
+1.08%
PRLD Prelude Therapeutics Incorporated
1.1857
-0.36%
ACXP Acurx Pharmaceuticals, Inc.
0.7312
-3.66%